NCT05025761

Brief Summary

This stepped-wedge cluster-randomized controlled trial with nested mixed methods study will assess the effectiveness, acceptability, feasibility and cost effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Myanmar.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 27, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

November 4, 2021

Status Verified

August 1, 2021

Enrollment Period

5 months

First QC Date

August 16, 2021

Last Update Submit

November 2, 2021

Conditions

Keywords

malariapreventionvectormigranteliminationvivaxfalciparumcommunity-deliveredintervention

Outcome Measures

Primary Outcomes (1)

  • Plasmodium spp. infection diagnosed by RDT

    Change in the number of Plasmodium spp. infections detected by RDT per week per village (SD Bioline P.f/P.v)

    Assessed weekly, longitudinally over 12 months

Secondary Outcomes (9)

  • Symptomatic malaria diagnosed by RDT

    Assessed weekly, longitudinally over 12 months

  • Plasmodium spp. infection as determined by polymerase chain reaction (PCR)

    Assessed weekly, longitudinally over 12 months

  • Plasmodium spp. drug resistance mutations

    Assessed weekly, longitudinally over 12 months

  • Prevalence of antibodies to Plasmodium spp.

    Assessed weekly, longitudinally over 12 months

  • Levels of antibodies to Plasmodium spp.

    Assessed weekly, longitudinally over 12 months

  • +4 more secondary outcomes

Study Arms (2)

Personal protection package

EXPERIMENTAL

A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN),insect repellent (DEET), Insecticide-treated clothes (ITC), and mobile and migrant population-tailored behavioural change communication (BCC) package

Other: Personal protection package

Control

NO INTERVENTION

No personal protection package

Interventions

The personal protection package will be distributed to mobile and migrant peoples in each village according to the stepped wedge design.

Personal protection package

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Capacity of Burnet Institute Myanmar to conduct field implementation
  • Presence of ICMV networks managed by NMCP and HPA
  • High malaria burden
  • High MMP activities
  • Available budget

You may not qualify if:

  • The township does not have an NMCP or HPA-provided ICMV network
  • The township is not under the administration of NMCP or HPA
  • The township has an ongoing armed conflict at the time of sampling
  • The location of the township is not geographically or politically feasible for the NMCP or HPA staff to conduct regular supervision visits
  • The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020)
  • The village has no MMPs
  • The village has no ICMVs actively working in the village
  • The village has a government health facility for malaria services
  • The village has an ICMV program operated by any organizations other than NMCP or HPA
  • Currently living in the selected villages/ worksites
  • Being any of the following types of workers: Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups); Seasonal agricultural laborers; Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo); Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.); Formal and informal cross-border migrant workers
  • Aged 18 years and over
  • Participants selected purposively from the same cohort of MMPs who have received the personal protection package during the study period
  • Aged over 18 years
  • From different levels of NMCP, EHOs and HPA
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Central Study Contacts

Freya JI Fowkes, DPhil

CONTACT

Win Han Oo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Stepped-wedge cluster-randomized controlled trial (one-way crossover) with nested mixed methods study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2021

First Posted

August 27, 2021

Study Start

January 1, 2022

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

November 4, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share